XNYIF Financial Statements & Analysis
Complete financial statements for XNYIF including income statement, balance sheet, and cash flow statement. Analyze XNYIF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-1.3% ↓
Net Income
-13.1% ↓
Gross Margin
35.0% ↑
Operating Margin
53.0% ↑
Balance Sheet
Current Ratio
33.4% ↑
Debt to Equity
8.8% ↓
Asset Turnover
-1.3% ↓
Cash Flow
Operating Cash Flow
348.0% ↑
Net Cash Flow
340.0% ↑
Free Cash Flow
188.4% ↑
Cash Flow to Debt
301.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 20.59B | 20.32B | 1.3% | |
| Gross Profit | 3.26B | 4.34B | 33.2% | |
| Operating Income | 2.19B | 3.30B | 51.0% | |
| Net Income | 946.93M | 822.48M | 13.1% | |
| EPS | 0.11 | 0.09 | 18.4% | |
| EBITDA | 4.13B | 5.42B | 31.3% | |
| Gross Margin | 15.84% | 21.38% | 35.0% | |
| Operating Margin | 10.61% | 16.24% | 53.0% | |
| Net Income Margin | 4.60% | 4.05% | 12.0% | |
| R&D Expenses | 635.24M | 580.13M | 8.7% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 20.32B | 20.59B | 26.63B | — | — |
| Gross Profit | 4.34B | 3.26B | 7.09B | — | — |
| Operating Income | 3.30B | 2.19B | 5.89B | — | — |
| Net Income | 822.48M | 946.93M | 4.19B | — | — |
| EPS | 0.09 | 0.11 | 0.47 | — | — |
| EBITDA | 5.42B | 4.13B | 7.78B | — | — |
| Gross Margin | 21.38% | 15.84% | 26.62% | — | — |
| Operating Margin | 16.24% | 10.61% | 22.13% | — | — |
| Net Income Margin | 4.05% | 4.60% | 15.72% | — | — |
| R&D Expenses | 580.13M | 635.24M | 766.52M | — | — |
Financial Metrics
Want to dive deeper into XNYIF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics